311 related articles for article (PubMed ID: 31163254)
1. MicroRNA heterogeneity in melanoma progression.
Thyagarajan A; Tsai KY; Sahu RP
Semin Cancer Biol; 2019 Dec; 59():208-220. PubMed ID: 31163254
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of deregulated microRNAs in uveal melanomas.
Falzone L; Romano GL; Salemi R; Bucolo C; Tomasello B; Lupo G; Anfuso CD; Spandidos DA; Libra M; Candido S
Mol Med Rep; 2019 Apr; 19(4):2599-2610. PubMed ID: 30816460
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in cutaneous melanoma: Role as diagnostic and prognostic biomarkers.
Ross CL; Kaushik S; Valdes-Rodriguez R; Anvekar R
J Cell Physiol; 2018 Jul; 233(7):5133-5141. PubMed ID: 29226953
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-221 and -222 pathway controls melanoma progression.
Felicetti F; Errico MC; Segnalini P; Mattia G; Carè A
Expert Rev Anticancer Ther; 2008 Nov; 8(11):1759-65. PubMed ID: 18983236
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-Directed Cancer Therapies: Implications in Melanoma Intervention.
Thyagarajan A; Shaban A; Sahu RP
J Pharmacol Exp Ther; 2018 Jan; 364(1):1-12. PubMed ID: 29054858
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA Expression Profile in Conjunctival Melanoma.
Larsen AC; Mikkelsen LH; Borup R; Kiss K; Toft PB; von Buchwald C; Coupland SE; Prause JU; Heegaard S
Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4205-12. PubMed ID: 27548891
[TBL] [Abstract][Full Text] [Related]
7. The role of microRNAs in melanoma.
Luo C; Weber CE; Osen W; Bosserhoff AK; Eichmüller SB
Eur J Cell Biol; 2014; 93(1-2):11-22. PubMed ID: 24602414
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of MicroRNA-1246 Is Associated with BRAF Inhibitor Resistance in Melanoma Cells with Mutant BRAF.
Kim JH; Ahn JH; Lee M
Cancer Res Treat; 2017 Oct; 49(4):947-959. PubMed ID: 28052651
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs role as potential biomarkers and key regulators in melanoma.
Varamo C; Occelli M; Vivenza D; Merlano M; Lo Nigro C
Genes Chromosomes Cancer; 2017 Jan; 56(1):3-10. PubMed ID: 27561079
[TBL] [Abstract][Full Text] [Related]
10. miRNAs as Key Players in the Management of Cutaneous Melanoma.
Lorusso C; De Summa S; Pinto R; Danza K; Tommasi S
Cells; 2020 Feb; 9(2):. PubMed ID: 32054078
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs in cancer: lessons from melanoma.
Greenberg E; Nemlich Y; Markel G
Curr Pharm Des; 2014; 20(33):5246-59. PubMed ID: 24479804
[TBL] [Abstract][Full Text] [Related]
12. A novel lncRNA-miRNA-mRNA competitive endogenous RNA network for uveal melanoma prognosis constructed by weighted gene co-expression network analysis.
Yu H; Cheng Y; Li W; Li Z; Wu P; Qiu S; Zeng B; Huang B
Life Sci; 2020 Nov; 260():118409. PubMed ID: 32926921
[TBL] [Abstract][Full Text] [Related]
13. miRNAs in Melanoma: Tumor Suppressors and Oncogenes with Prognostic Potential.
Wozniak M; Mielczarek A; Czyz M
Curr Med Chem; 2016; 23(28):3136-3153. PubMed ID: 27666934
[TBL] [Abstract][Full Text] [Related]
14. The miR-181 family promotes cell cycle by targeting CTDSPL, a phosphatase-like tumor suppressor in uveal melanoma.
Zhang L; He X; Li F; Pan H; Huang X; Wen X; Zhang H; Li B; Ge S; Xu X; Jia R; Fan X
J Exp Clin Cancer Res; 2018 Jan; 37(1):15. PubMed ID: 29382357
[TBL] [Abstract][Full Text] [Related]
15. Systematic Review and Meta-analysis of the Prognostic Significance of miRNAs in Melanoma Patients.
Sabarimurugan S; Madurantakam Royam M; Das A; Das S; K M G; Jayaraj R
Mol Diagn Ther; 2018 Dec; 22(6):653-669. PubMed ID: 30259393
[TBL] [Abstract][Full Text] [Related]
16. Small RNA deep sequencing discriminates subsets of extracellular vesicles released by melanoma cells--Evidence of unique microRNA cargos.
Lunavat TR; Cheng L; Kim DK; Bhadury J; Jang SC; Lässer C; Sharples RA; López MD; Nilsson J; Gho YS; Hill AF; Lötvall J
RNA Biol; 2015; 12(8):810-23. PubMed ID: 26176991
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-605 functions as a tumor suppressor by targeting INPP4B in melanoma.
Chen L; Cao Y; Rong D; Wang Y; Cao Y
Oncol Rep; 2017 Aug; 38(2):1276-1286. PubMed ID: 28656250
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators.
Daoud AZ; Mulholland EJ; Cole G; McCarthy HO
BMC Cancer; 2019 Nov; 19(1):1130. PubMed ID: 31752758
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.
Satzger I; Mattern A; Kuettler U; Weinspach D; Voelker B; Kapp A; Gutzmer R
Int J Cancer; 2010 Jun; 126(11):2553-62. PubMed ID: 19830692
[TBL] [Abstract][Full Text] [Related]
20. Update on melanoma epigenetics.
de Unamuno B; Palanca S; Botella R
Curr Opin Oncol; 2015 Sep; 27(5):420-6. PubMed ID: 26197354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
